SKI Market

A+| A| A-|

Indian Indices

Sensex

73,918.76 394.50
( 0.54%)

Global Indices

Nasdaq

50,884.98 77.97
(0.15%)

Dow Jones

7,407.31 -19.42
(-0.26%)

Hang Seng

65,160.26 1,135.66
(1.77%)

Nikkei 225

10,242.24 -130.96
(-1.26%)

Forex

USD-INR

95.22 -0.51
(-0.53%)

EUR-INR

109.67 -1.54
(-1.39%)

GBP-INR

126.98 -1.60
(-1.25%)

JPY-INR

0.59 0.00
(-0.77%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Lupin Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500257

INE326A01037

659.0470742

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

LUPIN

17.16

103490.01

EPS(TTM)

Face Value()

Div & Yield %

131.91

0.8

Back

dhatre udyog ltd

Wanbury standalone net profit rises 1191.80% in the December 2025 quarter

Feb 06,2026

Net profit of Wanbury rose 1191.80% to Rs 15.76 crore in the quarter ended December 2025 as against Rs 1.22 crore during the previous quarter ended December 2024. Sales rose 21.73% to Rs 162.45 crore in the quarter ended December 2025 as against Rs 133.45 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	162.45	133.45	22
OPM %	16.43	10.45	-
PBDT	19.61	4.61	325
PBT	15.87	1.29	1130
NP	15.76	1.22	1192

73,918.76 394.50 ( 0.54%)

50,884.98 77.97 (0.15%)

7,407.31 -19.42 (-0.26%)

65,160.26 1,135.66 (1.77%)

10,242.24 -130.96 (-1.26%)

95.22 -0.51 (-0.53%)

109.67 -1.54 (-1.39%)

126.98 -1.60 (-1.25%)

0.59 0.00 (-0.77%)